Pioglitazone: An Ongoing Misery in the Developing Countries to Which I can’t be Pragmatic!
Journal: Open Access Journal of Endocrinology (Vol.2, No. 2)Publication Date: 2018-04-13
Authors : Mina T Kelleni;
Page : 1-2
Keywords : pioglitazone; bladder cancer;
Abstract
In 2014, I've published an article warning against the widespread usage of pioglitazone in the developing countries though it has been banned or heavily restricted in all developed countries due to its proved causation with an increased incidence of bladder carcinoma [1].
Other Latest Articles
- Thyrotoxicosis Associated Channelopathy
- Papillary Carcinoma in Thyroglossal Duct Cyst
- Autosomal Dominant Hypophosphatemic Rickets: A Case Report
- Congenital Hyperinsulinism: Report of a New Mutation
- Is there an Escalation of Type 2 Diabetes Mellitus in Children and Adolescents: Therapeutics and Preventive Approach
Last modified: 2018-09-29 19:38:43